S 15261 is a new orally bioavailable anti-hyperglycemic agent that increases insulin sensitivity in various insulin-resistant animal models. References: Duhault J, Berger S, Boulanger M, Della Zuana O, Lacour F, Wierzbicki M. General pharmacology of S 15261, a new concept for treatment of diabetes. Arzneimittelforschung. 1998 Jul;48(7):734-44. PubMed PMID: 9706374.

纯度：≥98%

CAS：159978-02-6